
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **CDKN2A**: Known for its role in cell cycle regulation, often associated with tumor suppression.<br>- **PHGDH**: Involved in the serine biosynthesis pathway, often upregulated in cancer cells.<br>- **FABP5**: Fatty acid-binding protein involved in lipid metabolism, often linked to cancer progression.<br>- **EPCAM**: A cell adhesion molecule, often used as a marker for epithelial cells and cancer stem cells.<br>- **VCAN**: Versican, involved in cell adhesion, proliferation, and migration, often upregulated in cancer.<br>- **GSTP1**: Glutathione S-transferase, involved in detoxification processes, often overexpressed in cancer.<br>- **CRABP1/CRABP2**: Cellular retinoic acid-binding proteins, involved in retinoic acid signaling, which can influence cell differentiation and proliferation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT5, KRT14, KRT6B, KRT8**: Keratins are structural proteins in epithelial cells. KRT5 and KRT14 are typically associated with basal epithelial cells, while KRT8 is more common in luminal epithelial cells.<br>- **TTYH1**: Associated with cell proliferation and migration, often found in various epithelial tissues.<br>- **SLPI**: Secretory leukocyte protease inhibitor, often expressed in epithelial cells and involved in immune response.<br>- **CRYAB**: Alpha-crystallin B chain, a small heat shock protein, often expressed in epithelial cells and involved in stress response.<br>- **S100A1**: A member of the S100 protein family, involved in calcium signaling, often expressed in epithelial cells.<br>- **PERP**: A p53 apoptosis effector related to the desmosome, often found in epithelial cells.<br>- **LMO4**: A transcriptional regulator, often expressed in epithelial cells and involved in development and cancer.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:<br>- **KRT5, KRT14**: Strongly associated with basal epithelial cells, particularly basal-like breast cancer cells.<br>- **EPCAM**: Commonly expressed in epithelial cells, including those in breast tissue.<br>- **FABP5, PHGDH**: Frequently upregulated in breast cancer cells, particularly in aggressive subtypes.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of keratins (KRT5, KRT14) and other epithelial markers (EPCAM, SLPI, CRYAB), the most probable general cell type is **epithelial cells**. Given the context of breast cancer tissue, these are likely to be breast epithelial cells.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Basal-like Breast Cancer Cells**: High expression of KRT5 and KRT14, along with CDKN2A and PHGDH, suggests a basal-like phenotype, which is common in triple-negative breast cancer.<br>2. **Luminal Progenitor Cells**: Expression of KRT8 and EPCAM, along with markers like FABP5, could indicate a luminal progenitor phenotype.<br>3. **Myoepithelial Cells**: While less likely due to the lack of specific myoepithelial markers, the presence of basal keratins could suggest a myoepithelial origin.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically basal-like breast cancer cells. This is supported by the high expression of basal keratins (KRT5, KRT14) and other markers associated with aggressive breast cancer phenotypes. The top three probable subtypes are basal-like breast cancer cells, luminal progenitor cells, and myoepithelial cells, with basal-like breast cancer cells being the most likely subtype.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**:<br>   - The key functional markers (CDKN2A, PHGDH, FABP5, EPCAM, VCAN, GSTP1, CRABP1/CRABP2) are present in the provided marker list.<br>   - The key cell type markers (KRT5, KRT14, KRT6B, KRT8, TTYH1, SLPI, CRYAB, S100A1, PERP, LMO4) are also present in the marker list.<br>   - The annotation correctly identifies epithelial cells as the general cell type, supported by the presence of epithelial markers such as KRT5, KRT14, KRT8, and EPCAM.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of mixed cell types by identifying three probable subtypes: basal-like breast cancer cells, luminal progenitor cells, and myoepithelial cells.<br>   - The presence of markers like KRT5, KRT14, and EPCAM supports the identification of basal-like breast cancer cells and luminal progenitor cells.<br>   - While myoepithelial cells are considered, the annotation notes the lack of specific myoepithelial markers, which is a reasonable approach given the data.<br><br>Overall, the annotation is well-supported by the marker list and provides a comprehensive analysis of the potential cell types present in the breast cancer tissue dataset.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">epithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>basal-like breast cancer cells</li><li>luminal progenitor cells</li><li>myoepithelial cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided for the single-cell RNA sequencing dataset of breast cancer tissue are generally well-executed, with several strengths and a few areas for improvement.<br><br>**Strengths:**<br><br>1. **Correctness of Annotations:** The annotation correctly identifies epithelial cells as the main cell type, which is consistent with the presence of key epithelial markers such as KRT5, KRT14, KRT8, and EPCAM. This is scientifically accurate given the context of breast cancer tissue.<br><br>2. **Balanced Consideration of Markers:** The analysis considers a wide range of markers, including both functional markers (e.g., CDKN2A, PHGDH, FABP5) and cell type markers (e.g., KRT5, KRT14, KRT8). This balanced approach helps in capturing the complexity of the cell populations present.<br><br>3. **Comprehensive View:** The annotation provides a comprehensive view by identifying three probable subtypes: basal-like breast cancer cells, luminal progenitor cells, and myoepithelial cells. This reflects an understanding of the heterogeneity within breast cancer tissues.<br><br>4. **Consideration of Marker Rank:** The annotation does not explicitly mention the rank of markers, but it does focus on key markers that are known to be significant in breast cancer, which suggests an implicit consideration of marker importance.<br><br>**Weaknesses:**<br><br>1. **Marker Rank Consideration:** While the annotation implicitly considers marker importance, it could benefit from a more explicit discussion of the rank of markers. For instance, TTYH1 is listed first but is not emphasized in the analysis, which could be a missed opportunity to explore its significance.<br><br>2. **Myoepithelial Cell Consideration:** The annotation mentions myoepithelial cells as a possible subtype but notes the lack of specific markers. This is a reasonable approach, but it could be strengthened by discussing any indirect evidence or potential markers that might support this classification.<br><br>3. **Potential Oversights:** The annotation could explore the role of other markers like CRYAB and S100A1 in more detail, as they are mentioned but not deeply analyzed. This could provide additional insights into the cell populations.<br><br>Overall, the annotation is scientifically accurate and provides a well-rounded analysis of the cell types present in the dataset. It captures the general picture effectively, though it could be improved by explicitly addressing the rank of markers and exploring some markers in more detail.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    